CHICAGO (GenomeWeb) – Results from several highly anticipated immuno-oncology clinical trials were released yesterday at the annual meeting of the American Association for Cancer Research. All the studies included some analysis of molecular response biomarkers, but with variable takeaways for the future of companion testing in this rapidly accelerating field.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.